國家衛生研究院 NHRI:Item 3990099045/12915
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 911817      線上人數 : 997
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/12915


    題名: Radiation dose escalation can improve local disease control and survival among esophageal cancer patients with large primary tumor volume receiving definitive chemoradiotherapy
    作者: Lin, FC;Chang, WL;Chiang, NJ;Lin, MY;Chung, TJ;Pao, TH;Lai, WW;Tseng, YL;Yen, YT;Sheu, BS
    貢獻者: National Institute of Cancer Research
    摘要: Background This study aimed to investigate the correlation between primary tumor volume and cancer failure patterns in esophageal squamous cell carcinoma (ESCC) treated with definitive concurrent chemoradiotherapy (CCRT) and examine whether increasing radiation dose can improve the outcome. Methods We retrospectively reviewed 124 patients with stage III ESCC treated by definitive CCRT. The primary tumor volume calculated from the radiotherapy planning computed tomography scans was correlated to treatment response, time to disease progression, and overall survival. We further analyzed whether a higher radiation dose correlated with better disease control and patient survival. Results Patients with poor CCRT response had a larger primary tumor volume than those with good response (97.9vs64.3 cm(3),P= 0.032). The optimal cutoff value to predict CCRT response was 55.3 cm(3). Large primary tumor volume (>= 55.3 cm(3)) correlated with shorter time to tumor progression in the esophagus (13.6vs48.6 months,P= 0.033) compared with small tumor volume (< 55.3 cm(3)). For the large esophageal tumors (>= 55.3 cm(3)), radiation dose > 60 gray significantly prolonged the time to tumor progression in esophagus (20.3vs10.1 months,P= 0.036) and overall survival (12.2vs8.0 months,P= 0.030), compared with dose <= 60 gray. In contrast, higher radiation dose did not benefit local disease control or overall survival in the small esophageal tumors (< 55.3 cm(3)). Conclusion Large primary tumor volume correlates with poor local control and overall survival in ESCC treated with definitive CCRT. Radiation dose > 60 gray can improve the outcomes in patients with large primary tumor. Further prospective dose escalation trials are warranted.
    日期: 2020-08
    關聯: PLoS ONE. 2020 Aug;15(8):Article number e0237114.
    Link to: http://dx.doi.org/10.1371/journal.pone.0237114
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1932-6203&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000561027200039
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85089170795
    顯示於類別:[姜乃榕] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI000561027200039.pdf1429KbAdobe PDF249檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋